CN2912512Y - ECG detection circuit with excellent noise suppressing function - Google Patents

ECG detection circuit with excellent noise suppressing function Download PDF

Info

Publication number
CN2912512Y
CN2912512Y CN 200620078990 CN200620078990U CN2912512Y CN 2912512 Y CN2912512 Y CN 2912512Y CN 200620078990 CN200620078990 CN 200620078990 CN 200620078990 U CN200620078990 U CN 200620078990U CN 2912512 Y CN2912512 Y CN 2912512Y
Authority
CN
China
Prior art keywords
amplifier
output
input
resistance
phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 200620078990
Other languages
Chinese (zh)
Inventor
杨振江
刘全成
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200620078990 priority Critical patent/CN2912512Y/en
Application granted granted Critical
Publication of CN2912512Y publication Critical patent/CN2912512Y/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The utility model relates to a detection circuit of electrocardiogram signal (ECG signal), in particular to an ECG detection circuit which can greatly restrain the interruption of noises. The utility model is characterized in that a resistor of the resistor net of the inverting phase input of a first amplifier electrically is connected with a resistor of the inverting phase input net of a second amplifier; the electrical joint is introduced to the in-phase port of a fourth amplifier which is a voltage follower; the output of the voltage follower electrically is connected with the shielding port of the shielding cable of the educing wire; the joint enters the input of a fifth amplifier and is output by the fifth amplifier as a signal port of the ECG signal. The utility model has high common-mode rejection ratio, large enough pre-amplifier magnification times and appropriate bandwidth, therefore outputting genuine ECG signal.

Description

Has the high electrocardio testing circuit that suppresses the noise ability
Technical field
This utility model relates to a kind of testing circuit of electrocardiosignal, particularly has the high electrocardio testing circuit that suppresses the noise ability.
Background technology
Electrocardiosignal (ECG) amplifying circuit with high signal source internal resistance characteristics, except being used for increasing signal amplitude, so that outside further dealing with, show or writing down, the regulating action that also is used for the isolation signals source and carries out signals such as bandwidth compression.The design of sort circuit often will be considered:
1, input impedance
Since under electrocardioelectrode and the human epidermal between the muscular tissue or contact resistance than high many of the resistance of tissue itself, and easily variation, its equivalent circuit as shown in Figure 1.Wherein, Re is surface contacted resistance (tens K Ω is to hundreds of M Ω), and Ce is surface electrode equivalent capacity (tens pf are to several thousand pf), and Es is the uneven electromotive force (several MV are to tens MV) of electrode, and Rt is muscular tissue resistance (tens Ω are to tens K Ω).Capacitance Coupled when upper frequency between electrode and the tissue becomes important, but in fact electrocardiosignal is lower frequency, so the influence of capacitor C e can be ignored, but the resistance of Re, Es and Rt can directly influence quality of signals and amplitude when lower frequency.
2, common mode inhibition
When detecting electrocardio, because input impedance is very high, two pole plate effects that human body and near 220V alternating current power supply or near power line just play capacitor Cp (seeing Fig. 1 about 10Pf), with the air is medium, civil power 50Hz signal has been coupled in the human body,, has been added to amplifier input terminal by muscular tissue and electrode because the inflow of slight electric current is arranged, just because of the existence of this signal, can directly have a strong impact on the collection of electrocardiosignal.
3, Zui Jia signal to noise ratio
Because the electrocardio frequency is lower, the frequency band range of suitable control amplifier and amplification could obtain best signal to noise ratio showing or writing down in the cardiac electrical process.
And existing electrocardiosignal amplifying circuit all is to adopt measuring amplifier that three general discharge circuits the constitute amplifying circuit as electrocardiosignal, and its existing problem is also as three aspect reasons of last surface analysis.
Summary of the invention
The purpose of this utility model provides a kind of high electrocardio testing circuit that suppresses the noise ability that has, and it not only has high common mode rejection ratio and sufficiently high preposition amplification and suitable bandwidth.Make electrocardiosignal output undistorted.
The purpose of this utility model is to realize like this, has the high electrocardio testing circuit that suppresses the noise ability, which comprises at least core signal sensor, the measuring amplifier that the lead-out wire shielded cable of core signal sensor and three discharge circuits constitute, wherein the in-phase input end of measuring amplifier first amplifier that constitutes with three discharge circuits respectively of two of lead-out wire shielded cable holding wires and the in-phase input end of second amplifier are electrically connected, the output of first amplifier is electrically connected with the in-phase end and the end of oppisite phase of the 3rd amplifier respectively with the output of second amplifier, carry out electrocardiosignal by the 3rd amplifier and amplify output, first amplifier's inverting input and second amplifier's inverting input are amplified network by resistor network and outfan formation separately respectively, it is characterized in that: resistance in the resistor network of first amplifier's inverting input is electrically connected with a resistance in the second amplifier's inverting input network, its electric connection point is input to the in-phase end with the 4th amplifier, the 4th amplifier is a voltage follower, the output of voltage follower is electrically connected with the shielding end of above-mentioned lead-out wire shielded cable, its junction point enters the 5th amplifier input terminal, by the signal end of the 5th amplifier output as electrocardiosignal.
The output of described third level amplifier enters the electrocardiosignal treatment circuit after forming L type high pass filter by C3 and R10, the desirable 1.0uF of the C3 in the high pass filter wherein, and between the desirable 270k Ω of R10-330k Ω, optimum is got 300k Ω.
The output of described first amplifier is input to third level amplifier's inverting input by resistance R 5, and the output of second amplifier is input to the in-phase input end of third level amplifier by resistance R 6; Third level amplifier's inverting input and outfan and connecting resistance R7 and capacitor C 2; Between the in-phase input end of third level amplifier and the ground and connecting resistance R9 and capacitor C 1.
The optional precision of described third level amplifier is low floats the type operational amplifier, and R7 and R9 get 20k Ω, C1 and C2 gets 100pF.
Characteristics of the present utility model are: because resistance in the resistor network of first amplifier's inverting input is electrically connected with a resistance in the second amplifier's inverting input network, its electric connection point is input to the in-phase end with the 4th amplifier, the 4th amplifier is a voltage follower, the output of voltage follower is electrically connected with the shielding end of above-mentioned lead-out wire shielded cable, its junction point enters the 5th amplifier input terminal, by the signal end of the 5th amplifier output as electrocardiosignal.This " floating ground " circuit design, common-mode signal by resistance in the resistor network of getting first amplifier's inverting input respectively and a resistance in the second amplifier's inverting input network, amplify the right lower limb (RL) that goes to drive human body by the two-stage of the 4th amplifier, the 5th amplifier and make circuit have very high common mode inhibition capacity, can eliminate significantly for the interference of 50HZ alternating current power supply and extraneous other electrical noise interference simultaneously.
Description of drawings
Below in conjunction with the embodiment accompanying drawing this utility model is described further.
Fig. 1 is that surface electrode detects the electrocardio equivalent circuit;
Fig. 2 is this utility model circuit theory diagrams.
Among the figure: 1, lead-out wire shielded cable; 2, shielding end; 3, electrocardiosignal; 4, the electrocardiosignal treatment circuit 4; U1, first amplifier; U2, second amplifier; U3, the 3rd amplifier; U4, the 4th amplifier; U5, the 5th amplifier.
The specific embodiment
As shown in Figure 2, the three amplifiers typical case difference amplifier of forming to R7, R9, R11, R12, C1 and C2 by the first amplifier U1, the second amplifier U2, the 3rd amplifier U3, R1.Resistance R 3 one ends are electrically connected with the RA of electrocardiosignal 3, and the other end is electrically connected with the in-phase end of the first amplifier U1; Resistor network R1, the R11 that the first amplifier U1 inverting input connects determines the amplification of the first amplifier U1, and its amplification is approximately equal to the value of R11/R1.Resistance R 4 one ends are electrically connected with the LA of electrocardiosignal 3, and the other end is electrically connected with the in-phase end of the second amplifier U2; Resistor network R2, the R12 that the second amplifier U2 inverting input connects determines the amplification of the second amplifier U2, and its amplification is approximately equal to the value of R12/R2; The end of oppisite phase of the first amplifier U1 and the second amplifier U2 is connected with R2 by resistance R 1 respectively, junction point is input to the in-phase end of the 4th amplifier U4 again, the 4th amplifier U4 is a voltage follower, the output of voltage follower is electrically connected with the shielding end 2 of lead-out wire shielded cable 1, its junction point enters the inverting input of the 5th amplifier U5, the 5th amplifier U5 and resistance R 8, R13 constitute inverting amplifier, and R13/R8 is an amplification.Pass through the signal end RL of resistance R 14 backs by the 5th amplifier U5 output as electrocardiosignal 3.
The output of the first above-mentioned amplifier U1 is input to the inverting input of third level amplifier U3 by resistance R 5, and the output of the second amplifier U2 is input to the in-phase input end of third level amplifier U3 by resistance R 6; The inverting input of third level amplifier U3 and outfan and connecting resistance R7 and capacitor C 2; Between the in-phase input end of third level amplifier U3 and the ground and connecting resistance R9 and capacitor C 1.
The operational amplifier of first amplifier U1 in above-mentioned and the optional FET input type of the second amplifier U2, its input impedance can reach more than the 100m Ω.The low type operational amplifier, the desirable 10k Ω of R3 and R4, R1 and the desirable 1.0k Ω of R2, R11 and the desirable 20k Ω of R12, R5 and the desirable 10k Ω of R6, R7 and the desirable 20k Ω of R9, C1 and the desirable 100pF of C2 of floating of the optional precision of third level amplifier U3.Consider the existence of the polarization potential Es (see figure 1) of surface electrode, this part amplification should be controlled at about 20 times.
Need to prove by the 4th amplifier U4, the 5th amplifier U5 and R8, R13, R14 with from human body left arm, right arm input line gauze screen (shielding end 2) and forms " floating ground ".The operational amplifier of the 4th amplifier U4, the optional FET input type of the 5th amplifier U5 wherein, the desirable 10k Ω of R8, the desirable 390k Ω of R13, the desirable 510k Ω of R14.This part is owing to adopted " floating ground " circuit design, by getting the common-mode signal on R1 and the R2, amplify right lower limb (RL) and the screen layer that removes to drive human body by the 4th amplifier U4, the 5th amplifier U5 two-stage, make circuit have very high common mode inhibition capacity, can eliminate significantly for the interference of 50HZ alternating current power supply and extraneous other electrical noise interference.
The output of third level amplifier U3 enters electrocardiosignal treatment circuit 4 after forming L type high pass filter by C3 and R10, the desirable 1.0uF of the C3 in the high pass filter wherein, and between the desirable 270k Ω of R10-330k Ω, optimum is got 300k Ω.This part is mainly cut off the polarization potential that has been placed to, the time constant unsuitable excessive, otherwise signal is too slow.
This device passes through the actual use of " multi-functional electrocardio comprehensive tester ", " remote ecg telephone transmission system ", its anti-interference, reliability, and stability, very good etc. effect, all reached the requirement and the purpose of expecting.

Claims (4)

1, has the high electrocardio testing circuit that suppresses the noise ability, which comprises at least core signal sensor, the measuring amplifier that the lead-out wire shielded cable of core signal sensor and three discharge circuits constitute, wherein the in-phase input end of measuring amplifier first amplifier that constitutes with three discharge circuits respectively of two of lead-out wire shielded cable holding wires and the in-phase input end of second amplifier are electrically connected, the output of first amplifier is electrically connected with the in-phase end and the end of oppisite phase of the 3rd amplifier respectively with the output of second amplifier, carry out electrocardiosignal by the 3rd amplifier and amplify output, first amplifier's inverting input and second amplifier's inverting input are amplified network by resistor network and outfan formation separately respectively, it is characterized in that: resistance in the resistor network of first amplifier's inverting input is electrically connected with a resistance in the second amplifier's inverting input network, its electric connection point is input to the in-phase end with the 4th amplifier, the 4th amplifier is a voltage follower, the output of voltage follower is electrically connected with the shielding end of above-mentioned lead-out wire shielded cable, its junction point enters the 5th amplifier input terminal, by the signal end of the 5th amplifier output as electrocardiosignal.
2, the electrocardio testing circuit with high inhibition noise ability according to claim 1, it is characterized in that: the output of described third level amplifier enters the electrocardiosignal treatment circuit after forming L type high pass filter by C3 and R10, the desirable 1.0uF of the C3 in the high pass filter wherein, between the desirable 270k Ω of R10-330k Ω, optimum is got 300k Ω.
3, the electrocardio testing circuit with high inhibition noise ability according to claim 1, it is characterized in that: the output of described first amplifier is input to third level amplifier's inverting input by resistance R 5, and the output of second amplifier is input to the in-phase input end of third level amplifier by resistance R 6; Third level amplifier's inverting input and outfan and connecting resistance R7 and capacitor C 2; Between the in-phase input end of third level amplifier and the ground and connecting resistance R9 and capacitor C 1.
4, the electrocardio testing circuit with high inhibition noise ability according to claim 3, it is characterized in that: the optional precision of described third level amplifier is low floats the type operational amplifier, and R7 and R9 get 20k Ω, C1 and C2 gets 100pF.
CN 200620078990 2006-05-17 2006-05-17 ECG detection circuit with excellent noise suppressing function Expired - Fee Related CN2912512Y (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200620078990 CN2912512Y (en) 2006-05-17 2006-05-17 ECG detection circuit with excellent noise suppressing function

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200620078990 CN2912512Y (en) 2006-05-17 2006-05-17 ECG detection circuit with excellent noise suppressing function

Publications (1)

Publication Number Publication Date
CN2912512Y true CN2912512Y (en) 2007-06-20

Family

ID=38167114

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200620078990 Expired - Fee Related CN2912512Y (en) 2006-05-17 2006-05-17 ECG detection circuit with excellent noise suppressing function

Country Status (1)

Country Link
CN (1) CN2912512Y (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102499671A (en) * 2011-11-28 2012-06-20 中国科学技术大学 Ventricular repolarization high-frequency wave double-limb electrode detecting device
CN103796580A (en) * 2011-09-21 2014-05-14 索尼公司 Biological signal measuring device
CN104622460A (en) * 2014-12-31 2015-05-20 北京瀚景锦河科技有限公司 ECG signal collecting device
CN108186010A (en) * 2018-03-02 2018-06-22 南京大学 A kind of active electrode for electro-physiological signals detection
CN111387972A (en) * 2020-04-20 2020-07-10 广州易风健康科技股份有限公司 Weak current signal acquisition circuit and have this acquisition circuit's seat circle and toilet lid

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103796580A (en) * 2011-09-21 2014-05-14 索尼公司 Biological signal measuring device
CN103796580B (en) * 2011-09-21 2016-03-16 索尼公司 Biological signal measuring device
CN102499671A (en) * 2011-11-28 2012-06-20 中国科学技术大学 Ventricular repolarization high-frequency wave double-limb electrode detecting device
CN102499671B (en) * 2011-11-28 2013-11-06 中国科学技术大学 Ventricular repolarization high-frequency wave double-limb electrode detecting device
CN104622460A (en) * 2014-12-31 2015-05-20 北京瀚景锦河科技有限公司 ECG signal collecting device
CN108186010A (en) * 2018-03-02 2018-06-22 南京大学 A kind of active electrode for electro-physiological signals detection
CN111387972A (en) * 2020-04-20 2020-07-10 广州易风健康科技股份有限公司 Weak current signal acquisition circuit and have this acquisition circuit's seat circle and toilet lid
CN111387972B (en) * 2020-04-20 2023-10-31 广州易风健康科技股份有限公司 Weak current signal acquisition circuit and seat ring and toilet cover with same

Similar Documents

Publication Publication Date Title
CN101433461B (en) Detection circuit for high-performance brain electrical signal of brain-machine interface
CN101199418B (en) Brain impedance detection circuitry and EEG checking device
CN2912512Y (en) ECG detection circuit with excellent noise suppressing function
CN109381185A (en) A kind of surface myoelectric signal collection apparatus
CN104000584A (en) Weak signal acquisition circuit with high SNR (Signal to Noise Ratio)
CN103096216A (en) Audio processing circuit and earphone
CN109150123A (en) A kind of small-signal pre-amplification circuit of high-gain
CN105232034A (en) Electrode and circuit multiplex structure for detecting electrocardiograph signals and human impedance
CN206576860U (en) Anesthesia depth monitor
CN110289817A (en) A kind of small signal amplifier
CN112040356B (en) Microphone and loudspeaker integrated system
CN104706344A (en) Electrocardiosignal measurement collecting system
CN202843602U (en) Electrocardio remote mobile communication monitoring system
CN203416398U (en) Active noise reduction earphone circuit
CN206792405U (en) ECG detection device
CN209281373U (en) Direct current biasing for human body Collection equipment eliminates circuit
CN106175759A (en) Electromyographic signal collection circuit and Wearable device
CN103218200A (en) System and method for collecting audio signal by intelligent terminal
CN209826722U (en) Surface electromyogram signal acquisition device
CN204101170U (en) Hummer testing circuit
CN110882467A (en) Sleeping instrument
CN111431487A (en) Low-noise microphone preamplifier circuit
CN207427481U (en) A kind of microphone test device
CN206507946U (en) A kind of portable auditory evoked potential detection device based on sound card
CN207870892U (en) One kind being used for neonatal EEG signals detection device

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee